The Impact of Post-Hematopoietic Stem Cell Transplant Tyrosine Kinase Inhibitors in Philadelphia-Positive Acute Lymphoblastic Leukemia.

Q1 Medicine

Hematology/ Oncology and Stem Cell Therapy Pub Date : 2022-12-23 DOI:10.1016/j.hemonc.2021.07.003

Khalid Halahleh, Dalia Al Rimawi, Amal Abu Ghosh, Isra Muradi, Waleed Da'na, Mehdi Hamadani

引用次数: 2

查看原文本刊更多论文

造血干细胞移植后酪氨酸激酶抑制剂对费城阳性急性淋巴细胞白血病的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Hematology/ Oncology and Stem Cell Therapy Medicine-Hematology

CiteScore

4.30

自引率

0.00%

发文量

审稿时长

27 weeks

期刊介绍： Hematology Oncology and Stem Cell Therapy is an international, peer-reviewed, open access journal that provides a vehicle for publications of high-quality clinical as well as basic science research reports in hematology and oncology. The contents of the journal also emphasize the growing importance of hematopoietic stem cell therapy for treatment of various benign and malignant hematologic disorders and certain solid tumors.The journal prioritizes publication of original research articles but also would give consideration for brief reports, review articles, special communications, and unique case reports. It also offers a special section for clinically relevant images that provide an important educational value.